ARKG250411C17000
- 3.20
- 0.000.00%
ARK Genomic Revolution ETF Newsroom
10 Health Care Stocks Whale Activity In Today's Session
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today
CareDx Analyst Ratings
Keybanc Maintains Overweight on Schrodinger, Raises Price Target to $32
Schrodinger Analyst Ratings
Recursion Licenses HealthVerity's Real-World Data Covering 340M Lives To Power Its AI-Driven Recursion OS, Enhancing Clinical Trial Design, Feasibility, And Operations To Accelerate Therapeutic Development And Reduce Costs
Retail Buyers vs. Global Sellers: Is Now the Time to Jump into U.S. Stocks?
SA Analyst Upgrades: AAPL, PLTR, BABA, MU, NIO, TSM, UAL, SNOW, COIN
Trump's Tariff Backtrack: Tech Giants Set to Surge—Is It Time to Buy?
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?
Shares of Healthcare Technology Stocks Are Trading Higher. Some Stocks in the Sector Rose After the FDA Stated Plans to Phase Out Animal Testing Requirements for Monoclonal Antibodies and Other Drugs.
Recursion Pharmaceuticals Shares Are Up Today: What's Going On?
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Cathie Wood's Thursday Plays: Healthcare AI And Crypto — Ark Scoops Up Tempus AI and Coinbase Stock Amid Trump Tariff Crash
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements
Under the Deepseek effect, Goldman Sachs puts cold water on the Datacenter boom: the Global Datacenter utilization rate has reached its peak.
From the release of DeepSeek, which is a low-cost competitor to ChatGPT, to Microsoft scaling back its Global AI Datacenter projects, and Alibaba Director Zhang Yong warning about a bubble in USA AI infrastructure investments, multiple warning signals are flashing: the boom in AI Datacenters may soon be facing a cool down.
12 Health Care Stocks Moving In Thursday's After-Market Session
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $45